Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
324
324 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BL-M14D1Phase 32 trials
SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma
- EU-sourced KeytrudaPhase 32 trials
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer
- IparomlimabPhase 32 trials
Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- JAB-3312Phase 32 trials
Allist Pharmaceuticals, Inc. · KRAS P.G12C, Non-small Cell Lung Cancer, Colorectal Cancer
- JK-1201IPhase 32 trials
JenKem Technology Co., Ltd. · Glioblastoma Multiforme (GBM), Small Cell Lung Cancer
- JYP0322Phase 32 trials
Guangzhou JOYO Pharma Co., Ltd · Non Small Cell Lung Cancer, NSCLC (Advanced Non-small Cell Lung Cancer)
- NeladalkibNVL-655Phase 32 trials
Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor
- OBI-821OBI-833Phase 32 trials
OBI Pharma, Inc · Triple Negative Breast Cancer, Non-small Cell Lung Cancer
- OciperlimabBGB-A1217Phase 32 trials
BeOne Medicines (BeiGene) · Non Small Cell Lung Cancer, Advanced Malignancies
- OSE2101Phase 32 trials
OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- PF-08046054SGN-PDL1VPhase 32 trials
Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
- Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials
EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer
- SetidegrasibASP3082Phase 32 trials
Astellas · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
- SugemalimabPhase 32 trials
Akeso · NSCLC (Non-small Cell Lung Cancer), Extranodal NK/T-cell Lymphoma
- TGRX-326once a dayPhase 32 trials
Shenzhen TargetRx Co., Ltd. · Non-small Cell Lung Cancer, Non Small Cell Lung Cancer
- TQB2450Phase 32 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer
- TuvonralimabPhase 32 trials
Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- UliledlimabPhase 32 trials
TJ Biopharma Co., Ltd. · Non Small Cell Lung Cancer
- US-sourced KeytrudaPhase 32 trials
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer
- VEGF bispecific antibodyPhase 32 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Squamous Non-small-cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer
- VT3989Phase 32 trials
Vivace Therapeutics, Inc · Pleural Mesothelioma, Mesothelioma, Solid Tumor, Adult
- ABBV-1480Phase 31 trial
AbbVie · Non-Small Cell Lung Cancer
- adebelizumabPhase 31 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced or Metastatic Non-small Cell Lung Cancer
- Alflutinib MesylatePhase 31 trial
Allist Pharmaceuticals, Inc. · Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
- Atezolizumab followed by AtezolizumabPhase 31 trial
SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma
- Atigotatug+NivolumabBMS-986489Phase 31 trial
Bristol Myers Squibb · Extensive-Stage Small Cell Lung Cancer
- FHND9041Phase 31 trial
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Non Small Cell Lung Cancer
- HLX17Phase 31 trial
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer
- HS-20117PM1080Phase 31 trial
Hansoh BioMedical R&D Company · Non-Squamous Non-Small Cell Lung Cancer
- IcotinibPhase 31 trial
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
- IptilimumabPhase 31 trial
InSightec · Brain Tumor, Non Small Cell Lung Cancer
- JMKX001899Phase 31 trial
Jemincare · NSCLC (Non-small Cell Lung Cancer)
- MB12Proposed Pembrolizumab BiosimilarPhase 31 trial
mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer
- PaxlitaxelPhase 31 trial
Akeso · Advanced Squamous Non Small Cell Lung Cancer
- PlinabulinPhase 31 trial
BeyondSpring Pharmaceuticals Inc. · Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance
- QL1604Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer
- RilogrotugPhase 31 trial
AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome
- SB27Phase 31 trial
Samsung Bioepis Co., Ltd. · Non-small Cell Lung Cancer Stage IV
- SH-1028Phase 31 trial
Nanjing Sanhome Pharmaceutical, Co., Ltd. · Non-small Cell Lung Cancer
- YK-209APhase 31 trial
Suzhou Puhe Pharmaceutical Technology Co., LTD · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- MK-4830Phase 210 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma
- SI-B003Phase 210 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck
- SHR-9839Phase 28 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Advanced Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC)
- RO7247669Tobemstomig, RG6139Phase 26 trials
Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer
- SKB571Phase 26 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Lung Cancer (Non-Small Cell), Non-Small Cell Lung Cancer, Gastrointestinal Tumors
- Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials
Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)
- GFH276Phase 25 trials
Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)
- PalacaparibAZD9574Phase 25 trials
AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer
- SHR-1826Phase 25 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.